abstract |
The present invention relates to novel compounds of formula (I) or salts, solvates or prodrugs thereof, useful for the treatment of diseases or conditions mediated through glucokinase (GLK), such as type 2 diabetes. The present invention further relates to a process for the preparation of formula (I) and its use as a medicament for the treatment of diseases mediated by glucokinase.n n n n Formula In n n n n n n n n Wherein R 1 , R 2 , R 3 , n and m are as described in the specification. |